Cellectar Biosciences, Inc. — Director's Dealing 2016

Aug 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2016-07-15

Reporting Person: Longcor Jarrod (Sr. VP of Corp Dev & Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-15	Employee Stock Option (right to buy)	$2.93	A	75000	Acquired	2026-07-15	Common Stock (75000)	Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant.